Denis Glotz
Overview
Explore the profile of Denis Glotz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
119
Citations
3730
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Furian L, Heemann U, Bengtsson M, Bestard O, Binet I, Bohmig G, et al.
Transpl Int
. 2025 Jan;
37:13886.
PMID: 39867871
Highly sensitized (HS) patients in need of kidney transplantation (KTx) typically spend a longer time waiting for compatible kidneys, are unlikely to receive an organ offer, and are at increased...
2.
Masset C, Branchereau J, Buron F, Karam G, Rabeyrin M, Renaudin K, et al.
Front Immunol
. 2024 Jun;
15:1359381.
PMID: 38873595
Background: About 10-20% of pancreas allografts are still lost in the early postoperative period despite the identification of numerous detrimental risk factors that correlate with graft thrombosis. Methods: We conducted...
3.
Tambur A, Audry B, Glotz D, Jacquelinet C
Am J Transplant
. 2023 Jan;
23(1):45-54.
PMID: 36695620
The demand for donors' kidneys continues to increase amid a shortage of available donors. Managing policies to thoughtfully allocate this scarce resource is a complex process. Although human leukocyte antigen...
4.
Lion J, Le Maitre M, de Truchis C, Taupin J, Poussin K, Haziot A, et al.
Clin Transplant
. 2022 Dec;
37(3):e14851.
PMID: 36495142
The microvascular endothelium of the renal transplant is the first site of graft interaction with the host immune system and is often injured in chronic Antibody Mediated Rejection (AMR). Microvascular...
5.
Lion J, Le Maitre M, de Truchis C, Taupin J, Poussin K, Haziot A, et al.
Clin Transplant
. 2022 Sep;
36(12):e14815.
PMID: 36114597
The microvascular endothelium of the renal transplant is the first site of graft interaction with the host immune system and is often injured in chronic Antibody Mediated Rejection (AMR). Microvascular...
6.
Vengadessane S, Viglietti D, Sauvageon H, Glotz D, Lefaucheur C, Madelaine I, et al.
Ann Pharm Fr
. 2022 Jul;
81(1):152-162.
PMID: 35792151
Objectives: The aims of this study were to assess medication adherence to immunosuppressive treatment in kidney transplanted patients, to identify predictive factors of medication non-adherence and to analyse its impact...
7.
Naesens M, Loupy A, Hilbrands L, Oberbauer R, Bellini M, Glotz D, et al.
Transpl Int
. 2022 Jun;
35:10137.
PMID: 35669977
Conditional marketing authorization (CMA) facilitates timely access to new drugs for illnesses with unmet clinical needs, such as late graft failure after kidney transplantation. Late graft failure remains a serious,...
8.
Seron D, Rabant M, Becker J, Roufosse C, Bellini M, Bohmig G, et al.
Transpl Int
. 2022 Jun;
35:10135.
PMID: 35669975
The diagnosis of acute T cell-mediated rejection (aTCMR) after kidney transplantation has considerable relevance for research purposes. Its definition is primarily based on tubulointerstitial inflammation and has changed little over...
9.
Naesens M, Budde K, Hilbrands L, Oberbauer R, Bellini M, Glotz D, et al.
Transpl Int
. 2022 Jun;
35:10136.
PMID: 35669974
In kidney transplant recipients, late graft failure is often multifactorial. In addition, primary endpoints in kidney transplantation studies seek to demonstrate the short-term efficacy and safety of clinical interventions. Although...
10.
Roufosse C, Becker J, Rabant M, Seron D, Bellini M, Bohmig G, et al.
Transpl Int
. 2022 Jun;
35:10140.
PMID: 35669973
Antibody-mediated rejection (AMR) is caused by antibodies that recognize donor human leukocyte antigen (HLA) or other targets. As knowledge of AMR pathophysiology has increased, a combination of factors is necessary...